Skip to main content
. 2022 May 27;14(11):2675. doi: 10.3390/cancers14112675

Figure 3.

Figure 3

Subgroup analyses according to treatment type in OS (a) and DFS/PFS (b). Lines (○) indicate 95% CIs. Diamond (♦) indicates the pooled effect size.